Drug Shortage Report for PRIORIX
Report ID | 82762 |
Drug Identification Number | 02239208 |
Brand name | PRIORIX |
Common or Proper name | Combined measles, mumps and rubella vaccine, live, attenuated |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | MUMPS VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED WATER |
Strength(s) | 10000UNIT 1000UNIT 1000UNIT 0.5ML |
Dosage form(s) | KIT POWDER FOR SOLUTION |
Route of administration | SUBCUTANEOUS INTRAMUSCULAR |
Packaging size | 10's |
ATC code | J07BD |
ATC description | VIRAL VACCINES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2019-04-24 |
Estimated end date | 2019-07-12 |
Actual end date | 2019-07-12 |
Shortage status | Resolved |
Updated date | 2019-07-13 |
Company comments | Delay in supply of GSK Diluent (packs of 10s) required for use with vaccine. Alternate supply of GSK Diluent available in packs of 100. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2019-07-13 | English | Compare |
v6 | 2019-07-12 | French | Compare |
v5 | 2019-07-12 | English | Compare |
v4 | 2019-05-23 | French | Compare |
v3 | 2019-05-23 | English | Compare |
v2 | 2019-04-29 | French | Compare |
v1 | 2019-04-29 | English | Compare |
Showing 1 to 7 of 7